|
|
|
|
|
|
|
英文 English
|
|
|
Nine hospitals offer pioneering knee repair therapy (2021/12/03)
A new law has opened the door for cutting edge treatments for knee pain in Taiwan. The pioneering implant therapy known as ACI is now available, and could revolutionize care for people with joint problems. ACI involves grafting some of the patient's own cartilage cells into the damaged knee, to help it regenerate. The treatment can allow patients to return to normal activity with zero knee pain.
Mr. Chen’s life was brought to a standstill when his knees began to degenerate. He even got an artificial knee replacement. But after successful ACI therapy, now he can walk as well as ever.
Chen Hsin-cheng
Knee replacement patient
From time to time I walk all the way from our house on the first floor up to the 14th floor. I don’t want to take a walking stick or use a wheelchair. I’m autonomous. Today I feel the procedure was really worth it.
Our knee joints are silent heroes, working seamlessly on every step we take. But for many, repetitive strain or a lack of care can damage our knees. In the past, the only solution was to get an artificial knee replacement, which can be tough to recover from. In recent years, ACI has become an alternative.
ACI has been approved by the new Special Medical Treatment Law, and many of Taiwan’s big hospitals have got licenses to offer the therapy. So far, 45 patients have had ACI and experienced the regrowth of their knee cartilage. Early research suggests ACI can reduce knee pain, with little risk of adverse reactions.
Dr. Hsiao Chin-fu
Institute of Population Health Sciences
A truly appropriate study would involve all the participants, all the patients, using the drug. That way, if we collect the data in a routine manner, it won’t be as confined as traditional clinical trials were in the past. The efficacy of the drug will be extended to a wider demographic.
The Institute of Population Health Sciences has signed a contract with a biotech company to further analyze data from nine hospitals, which they hope will expedite clinical trials.
Shih Chung-liang
Deputy Minister of Health and Welfare
You have a guarantee, whether in the research, in the product manufacturing, or among patients. We’ll do everything to push this forward on every level, so that Taiwan can truly become the biotech island of Asia.
The Ministry of Health and Welfare places high hopes in the research. For an aging society, caring for degenerative diseases must be a priority. An exponential number of people will develop joint problems in the coming years, and hospitals want to get ready.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
中文 Chinese
|
|
|
國衛院與醫療界合作分析膝軟骨細胞治療
特管法上路後開放自體軟骨細胞移植，過往要換人工膝關節的患者也多了新選項。國衛院現在攜手生技公司，與9家醫院合作分析膝軟骨細胞治療，希望透實證數據加速臨床試驗申請。
陳先生兩隻膝蓋都退化，萬念俱灰，一度要換成人工膝關節，但細胞治療奏效，現在走起路來，跟正常人沒兩樣！
[[患者 陳信呈]]
“偶爾的話，就從我們家，1樓走到14樓，我不要拿柺杖，不要坐輪椅，我生活能自理，我覺得今天，做這個治療就很值得了”
人體的膝關節，讓人能行動自如，行萬里路，但不少人因頻繁使用或使用不當耗損，嚴重患者過往只能換裝人工關節，但有適應或復健問題。近來自體軟骨細胞移植，成為治療新選擇！
特管法上路開放自體軟骨細胞移植，各大醫院陸續申請過關，目前共有45位患者透過細胞療法治療，都出現軟骨新生情形。初步顯示可改善病人疼痛，也沒發生嚴重不良反應！
[[國衛院群健所研究員蕭金福]]
“真正的一個比較適當的研究，應該是說所有的受試者，所有的病人都可以使用這個藥，這樣子的話我們是常規性的，去蒐集它的資料的話，那就不會像過去的，傳統臨床試驗那麼侷限，藥品的療效性推廣的族群，就會比較寬一點”
國衛院群健所現在更和生技公司簽署合作，希望透過9家醫院，進一步分析實證資料，加速臨床試驗。
[[衛福部次長 石崇良]]
“不論是在研發端，不論是在產業端，不論是在病人端，也能夠獲得保障的，各個層面上也能夠，全力的來推廣，讓台灣成為，真正在亞洲的一個生技島”
衛福部也對研究寄予深切期望，畢竟在高齡化社會下，越來越多國人可能都得面對關節危機。
|
|
|
|
|
|
|
|
|